| ￥750 | |
| Z03822 | |
|
|
|
|
|
|
|
|
|
| Species | Porcine | |
| Protein Construction |
|
|
| Purity | ≥ 95% as analyzed by SDS-PAGE | |
| Endotoxin Level | < 0.2 EU/μg of protein by gel clotting method | |
| Biological Activity | ED50 < 1.0 ng/ml, measured by a cell proliferation assay using BALB/3T3 cells, corresponding to a specific activity of > 1.0 ×106 units/mg. | |
| Expression System | E. coli | |
| Theoretical Molecular Weight | 16.4 kDa | |
| Apparent Molecular Weight | 20.1 kDa, on SDS-PAGE under reducing conditions | |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4 | |
| Reconstitution | Before opening, centrifuge the vial briefly to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O up to 100 μg/ml | |
| Storage & Stability | Upon receiving, this product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable up to 1 week at 4 °C or up to 3 months at -20 °C or below. Avoid repeated freeze-thaw cycles. |
?
The ED50 as determined by a cell proliferation assay using? BALB/3T3 cells is 0.1310 ng/ml ?
Lane 1: 2 µg of FGF-basic，Porcine under reducing condition (R)
Lane 2: 2 µg of FGF-basic，Porcine non-reducing condition (NR) (N)
The purity is greater than 95% as analyzed by SDS-PAGE
?| Target Background | Fibroblast Growth Factor-basic (FGF-basic), also known as FGF-2, is a pleiotropic cytokine. FGF-basic is produced by fibroblasts, and vascular cells. It regulates a variety of processes including cell proliferation, differentiation, survival, adhesion, motility, apoptosis, limb formation and wound healing. FGF-basic can be tumorigenic due to its role in angiogenesis and blood vessel remodeling. |
| Synonyms | Fibroblast Growth Factor-basic; FGF-2; BFGF; FGFB; HBGF-2; bFGF; Prostatropin |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
